EUVIMEDEUVIMED entdecken
Crossref

Interleukin 5 as a therapeutic target in severe asthma

Hubert Bajer, Rafał Pawliczak

Alergologia Polska - Polish Journal of Allergology · 2026 · 13 (1) · 21-27

DOI: 10.5114/pja.2026.159591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alergologia Polska - Polish Journal of Allergology, 2026. Verfasst von Hubert Bajer und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bajer, H., & Pawliczak, R. (2026). Interleukin 5 as a therapeutic target in severe asthma. Alergologia Polska - Polish Journal of Allergology, 13(1), 21-27. https://doi.org/10.5114/pja.2026.159591

Vancouver

Bajer H, Pawliczak R. Interleukin 5 as a therapeutic target in severe asthma. Alergologia Polska - Polish Journal of Allergology. 2026;13(1):21-27. doi:10.5114/pja.2026.159591

BibTeX
@article{Bajer2026,
  author = {Bajer, Hubert and Pawliczak, Rafał},
  title = {Interleukin 5 as a therapeutic target in severe asthma},
  journal = {Alergologia Polska - Polish Journal of Allergology},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {21--27},
  doi = {10.5114/pja.2026.159591}
}
Kostenlos starten →